- Home
- usa massachusetts
- Companies
Refine by
Medical Industry Technology In Massachusetts
34 companies found
Technologybased inRehovot, ISRAEL
Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
DSP-5336 is a small molecule inhibitor against the binding of menin and mixed-lineage leukemia (MLL) protein. Menin is a scaffold nuclear protein that plays various key roles in biological pathways, including cell growth regulation, cell cycle ...
Technologybased inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
Revvity Omics is at the forefront of pioneering advancements in healthcare through our sponsored testing programs. Our focus is on both common and rare disorders, and our mission is to empower individuals, promote early diagnosis, and contribute to ...
Technologybased inBoston, MASSACHUSETTS (USA)
Statsols is the company behind nQuery. nQuery is the complete trial design platform to make clinical trials faster, less costly and more successful. For over 20 years, we have worked with biostatisticians and researchers all over the world to ensure ...
Adaptive trials can reduce the length of your trial by up to ...
Technologybased inBoston, MASSACHUSETTS (USA)
People living with rare and devastating diseases are our Guiding Star. We believe it is our responsibility to listen to, understand, and change the lives of patients and those who work tirelessly to help them. Our mission is to transform the lives ...
People with rare diseases often wait years to receive a proper diagnosis and many never receive one at all. RARE ANSWERS™ is a system of innovative and sustainable tools designed to help shorten the diagnostic journey and time to initiating ...
Technologybased inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
Kephera is developing a test for Zika virus infection with support from a grant from the National Institutes of Health. Kephera’s Zika project is based on the identification of Zika-specific and Dengue-specific epitopes within the viral ...
Technologybased inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
We’re investigating a portfolio of other small molecule medicines aimed at treating the underlying cause of CF. This includes CFTR potentiators, which are designed to keep CFTR proteins at the cell surface open longer to improve the flow of ...
Technologybased inWatertown, MASSACHUSETTS (USA)
Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies. We are inventing new ways to design ...
Technologybased inWoburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Prostate cancer is the most prevalent cancer among men, and it is the second leading cause of cancer death among men in the United States. More than 500,000 cases are diagnosed annually. In the U.S. this year, 1 in 6 males will develop the disease ...
Technologybased inMaynard, MASSACHUSETTS (USA)
NorthEast Monitoring is committed to advancing Holter technology with our innovative ambulatory cardiac hardware and software solutions. We created the world’s FIRST 14-DAY Holter and event recorder, provide flexible licensing models for our ...
An enabling piece of web-based technology for many of NorthEast Monitoring’s products. LX Remote moves data between a remote site and a central analysis site. For example, consider a cardiology practice with multiple offices for patients ...
Technologybased inBoston, MASSACHUSETTS (USA)
Like our customers and their consumers, we needed a real change in the probiotic world that would result in products with benefits we can all feel. We knew current probiotics on the market deliver unpredictable benefits for some people, while not ...
Yso4 is an exploratory program targeting the gut-brain axis for the treatment of mood disorders. Over the last 5 years, there has been increasing evidence that the gut microbiome was associated with neurological and behavioral disorders, which led ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will be fundamental to help the world in rethinking what's ...
Technologybased inParis, FRANCE
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: To reconstruct damaged tissue and restore its natural function. Our mission is to disrupt the field of surgery and ...
Technologybased inMilano, ITALY
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its ...
Technologybased inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this paradigm is limited ...
Technologybased inIndianapolis, INDIANA (USA)
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed ...
Technologybased inBoston, MASSACHUSETTS (USA)
Neoclease is at the forefront of advancing gene editing technologies with a mission to transform healthcare by curing genetic diseases rather than just treating them. Utilizing a bespoke approach, the company develops tailored nucleases designed to ...
Neoclease is pioneering the future of precision medicine through advanced technology in synthetic biology and generative AI. By developing synthetic nucleases, the company enhances gene editing processes to achieve unprecedented specificity and ...
Technologybased inWoburn, MASSACHUSETTS (USA)
Founded in 2007, HUABIO is dedicated to developing curated, high-quality antibodies that advance innovation. We're passionate about the accuracy, efficiency, and consistency of our products. We devote our company mission to the disruption of an ...
Western blot analysis of GARS on Raji cell lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (ET1610-67, 1/500) was used in 5% BSA at room temperature for 2 ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the ...
Accuracy is everything. Better adenoma detection can boost any GI practice’s standard of care. SKOUT uses advanced computer-vision technology to better recognize colorectal polyps. Gastroenterologists get real-time feedback during ...
